The structure, genetic polymorphisms, expression and biological functions of complement receptor type 1 (CR1/CD35)

被引:55
|
作者
Liu, Dong [1 ,2 ]
Niu, Zhong-Xiang [1 ]
机构
[1] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Tai An, Shandong, Peoples R China
[2] Jinan Anim Husb & Vet Bur, Jinan, Peoples R China
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; MANNAN-BINDING LECTIN; C-REACTIVE PROTEIN; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; MEDIATES INHIBITORY SIGNALS; FOLLICULAR DENDRITIC CELLS; IGG IMMUNE-COMPLEXES; BLOOD-GROUP ANTIGENS; T-DEPENDENT ANTIGEN; C3B C4B RECEPTOR;
D O I
10.3109/08923970902845768
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The complement system is comprised of soluble and cell surface associated proteins that recognize exogenous, altered, or potentially harmful endogenous ligands. In recent years, the complement system-particularly component C3 and its receptors-have been demonstrated to be a key link between innate and adaptive immunity. Complement receptor type 1 (CR1), the receptor for C3b/C4bcomplement peptides, has emerged as a molecule of immense interest in gaining insight to the susceptibility, pathophysiology, diagnosis, prognosis and therapy of such diseases. In this review, we wish to briefly bring forth the structure, genetic polymorphisms, expression and biological functions of CR1.</.
引用
收藏
页码:524 / 535
页数:12
相关论文
共 50 条
  • [41] ERYTHROPOIETIN THERAPY IN HUMANS INCREASES ERYTHROCYTE EXPRESSION OF COMPLEMENT RECEPTOR-TYPE-1 (CD35)
    HEBERT, LA
    BIRMINGHAM, DJ
    DILLON, JJ
    COSIO, FG
    SHEN, XP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 4 (10): : 1786 - 1791
  • [42] Expression of complement receptors 1 (CR1/CD35) and 2 (CR2/CD21), and co-signaling molecule CD19 in cattle
    Pringle, Eric S.
    Firth, Matthew A.
    Chattha, Kuldeep S.
    Hodgins, Douglas C.
    Shewen, Patricia E.
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2012, 38 (04): : 487 - 494
  • [43] Erythrocyte complement receptor 1 (CR1) expression level is not associated with polymorphisms in the promoter or 3′ untranslated regions of the CR1 gene
    Cockburn, IA
    Rowe, JA
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2006, 33 (01) : 17 - 20
  • [44] CR1 (complement receptor 1, or CD35) ligation triggers association with Fas-Associated Phosphatase-1 (FAP-1) in human erythrocytes
    Ghiran, Ionita Calin
    Klickstein, Lloyd
    Karchanaphanurach, Pallop
    Golan, David
    Nicholson-Weller, Anne
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S76 - S76
  • [45] COMPLEMENT RECEPTOR TYPE-1 (CR-1, CD35) IS PACKAGED IN SECONDARY GRANULES OF HUMAN NEUTROPHILS (PMN)
    ROBINSON, JM
    JACK, RM
    MOLECULAR BIOLOGY OF THE CELL, 1992, 3 : A86 - A86
  • [46] Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome
    Wang, FS
    Chu, FL
    Jin, L
    Li, YG
    Zhang, Z
    Xu, D
    Shi, M
    Wu, H
    Moulds, JM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2005, 139 (01): : 112 - 119
  • [47] Lymphocyte activation by immune complexes: Possible role for CR1 (CD35)
    Quintero-Del-Rio, AI
    Jarvis, JN
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S36 - S36
  • [48] Complement Receptor 1 (CR1/CD35)-expressing retinal pigment epithelial cells as a potential therapy for age-related macular degeneration
    Simmons, Ken T.
    Mazzilli, John L.
    Mueller-Ortiz, Stacey L.
    Domozhirov, Aleksey Y.
    Garcia, Charles A.
    Zsigmond, Eva M.
    Wetsel, Rick A.
    MOLECULAR IMMUNOLOGY, 2020, 118 : 91 - 98
  • [49] Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
    Ogembo, Javier G.
    Kannan, Lakshmi
    Ghiran, Ionita
    Nicholson-Weller, Anne
    Finberg, Robert W.
    Tsokos, George C.
    Fingeroth, Joyce D.
    CELL REPORTS, 2013, 3 (02): : 371 - 385
  • [50] The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms
    Cohen, JHM
    Atkinson, JP
    Klickstein, LB
    Oudin, S
    Subramanian, VB
    Moulds, JM
    MOLECULAR IMMUNOLOGY, 1999, 36 (13-14) : 819 - 825